ELRN Stock Overview
A venture capital firm specializing in early stage and seed investment. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 2/6 |
Elron Ventures Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$4.42 |
52 Week High | US$7.25 |
52 Week Low | US$3.38 |
Beta | 0.73 |
11 Month Change | 29.48% |
3 Month Change | 1.68% |
1 Year Change | -21.00% |
33 Year Change | -62.07% |
5 Year Change | -8.98% |
Change since IPO | -98.81% |
Recent News & Updates
Recent updates
Shareholder Returns
ELRN | IL Diversified Financial | IL Market | |
---|---|---|---|
7D | -5.8% | 1.2% | 1.8% |
1Y | -21.0% | 47.7% | 24.0% |
Return vs Industry: ELRN underperformed the IL Diversified Financial industry which returned 47.7% over the past year.
Return vs Market: ELRN underperformed the IL Market which returned 24% over the past year.
Price Volatility
ELRN volatility | |
---|---|
ELRN Average Weekly Movement | 10.6% |
Diversified Financial Industry Average Movement | 3.7% |
Market Average Movement | 4.1% |
10% most volatile stocks in IL Market | 7.4% |
10% least volatile stocks in IL Market | 2.9% |
Stable Share Price: ELRN's share price has been volatile over the past 3 months compared to the IL market.
Volatility Over Time: ELRN's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of IL stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1962 | 8 | Yaron Elad | www.elronventures.com |
Elron Ventures Ltd is a venture capital firm specializing in early stage and seed investment. The firm prefers to invest in B2B software, cybersecurity, enterprise software or healthcare industries. The firm prefers to invest in Israel sector.
Elron Ventures Ltd Fundamentals Summary
ELRN fundamental statistics | |
---|---|
Market cap | ₪211.50m |
Earnings (TTM) | -₪26.39m |
Revenue (TTM) | ₪40.17m |
5.3x
P/S Ratio-8.0x
P/E RatioIs ELRN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ELRN income statement (TTM) | |
---|---|
Revenue | US$11.02m |
Cost of Revenue | US$0 |
Gross Profit | US$11.02m |
Other Expenses | US$18.26m |
Earnings | -US$7.24m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.14 |
Gross Margin | 100.00% |
Net Profit Margin | -65.70% |
Debt/Equity Ratio | 8.3% |
How did ELRN perform over the long term?
See historical performance and comparison